About this trial
Placenta accreta rates are rising alongside the rising rates of caesarean deliveries. This has lead to a vast number of studies negotiating the histopathological nature, risk factors and outcomes of pregnancies complicated with placenta accreta. In the study the investigators re discussing the outcome of different plans of management of placenta accreta, namely caesarean hysterectomy and focal myometrium resection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Singleton pregnancy with living fetus
Average liquor: 5-25 cm
Gestational age ≥ 34 weeks at time of termination
Previous lower segment cesarean section/s
Disqualifiers
Hepatic, cardio-pulmonary or coagulation disorders
Hemoglobin< 9.5g/dl
Ruptured membranes
Need for emergency delivery as Antepartum hemorrhage or contractions
Trial population
A total number of 36 pregnant patients at or after 34 weeks diagnosed of having placenta accreta spectrum were admitted and managed in Kasr Al-Ainy School of Medicine Hospital.
Trial design
Cohort
Prospective
Treatments tested in this trial
Caesarean Hysterectomy
Procedure/SurgeryCaesarean delivery followed by hysterectomy
Conservative management
Procedure/SurgeryFocal myometrium resection of the area of diseased myometrium after delivery
Treatment groups
Trial outcomes
Primary outcomes
operative blood loss
hemoglobin deficit in mg/dl
Secondary outcomes
operative blood loss
visual estimation of operative blood loss in ml
need for blood products transfusion
no of blood products transfused in both groups in no. of units
adjacent organ injuries
rates of urinary bladder or ureteric injuries
operative time
operative time in minutes
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: